Registration of medicines in Kazakhstan is a multi-stage process, starting with the submission of the corresponding dossier. A dossier is a set of documents confirming the safety, effectiveness and quality of a medicinal product.
Cooperation with Adalan LLP when registering medicines provides clients with an integrated approach. Our experience, highly qualified personnel, readiness to adapt and changes in legislation make us a reliable partner on the path to introducing innovative medicines to the market.
Adalan LLP provides a range of services to support the process of registration, re-registration, and amendments to the registration dossier for medicines.
Medicines that are imported into the territory of Kazakhstan must undergo full registration with the authorized bodies for its subsequent sale in the territory of Kazakhstan.
After a medicinal product has been registered, re-registered, or changes have been made to the registration documents, the relevant information is entered into the State Register of Medicines of Kazakhstan
The procedure for conducting the examination of medicines and the timing are determined by the order of the Minister of Health of the Republic of Kazakhstan dated January 27, 2021 No. KR DSM-10 “On approval of the Rules for conducting the examination of medicines and medical devices.